Thousands more people in Northern Ireland will be invited for bowel cancer screening after the Department of Health announced a major expansion of the programme starting on 2 November 2026. The phased rollout will eventually see everyone aged 50 to 74 eligible for screening by 2031, bringing Northern Ireland into line with the rest of the UK after years of lagging behind.
Currently, Northern Ireland is the only UK nation where screening begins at 60 rather than 50. According to Cancer Research UK, England, Scotland and Wales already offer screening from age 50. The expansion marks a significant shift in public health policy for the region, with the potential to detect hundreds of additional cancers at earlier, more treatable stages.
How the rollout will work
The expansion follows a carefully staged timetable:
- 2 November 2026: People aged 59 become eligible
- April 2027: 58-year-olds join the programme
- 2031: Full coverage for everyone aged 50 to 74
Once fully implemented, an additional 135,000 people will be invited for screening each year—an 80% increase in participation compared with current levels. The Department of Health anticipates annual savings of between £1.7 million and £2 million once the programme reaches full capacity.
The screening test itself is a simple at-home kit called a faecal immunochemical test (FIT), which detects tiny amounts of blood in poo that may indicate cancer or pre-cancerous growths called polyps. Participants collect a small sample and post it to a laboratory for analysis.
What ministers and officials said
Health Minister Robbie Butler emphasised both the clinical and economic benefits of the expansion:
“I am delighted to announce this significant expansion of the Northern Ireland Bowel Cancer Screening Programme. Extending screening to people aged 50 to 59 will help identify more cancers at an earlier stage, when treatment is most effective. This investment will not only improve outcomes for patients but is also expected to deliver annual health service savings of between £1.7 million and £2 million once fully implemented. I want to thank Health and Social Care staff and officials across Northern Ireland who have worked tirelessly to put the infrastructure and arrangements in place to make this expansion possible. Most importantly, I would strongly encourage everyone who receives a screening kit to take part. Bowel cancer screening saves lives.”
Professor Lourda Geoghegan, Deputy Chief Medical Officer, described the announcement as “a landmark step”:
“This is a landmark step for bowel cancer screening in Northern Ireland. Bowel cancer is one of the most common cancers we face, with more than 1,300 people diagnosed with colorectal cancer each year. Screening is one of the most effective ways to detect the disease early, when treatment has the best chance of success. It can also identify changes in the bowel before cancer develops. Once fully implemented, the programme will invite an additional 135,000 people every year, increasing participation by around 80% compared with current screening levels. A phased rollout will ensure screening, diagnostic and treatment services can manage the increased demand while maintaining high standards of care.”
Genevieve Edwards, Chief Executive of Bowel Cancer UK, welcomed the move:
“We’re delighted that the Department of Health in Northern Ireland has funded the phased extension of bowel cancer screening to people aged 50–74. This is a significant step towards improving bowel cancer survival in Northern Ireland. It will give thousands more people the opportunity to take part in screening, helping to find more cancers earlier when the disease is easier to treat and the chances of survival are higher. We look forward to seeing the programme being rolled out as quickly and safely as possible.”
Catching up with the rest of the UK
Northern Ireland’s expansion follows years of campaigning by cancer charities and comes four years after the UK National Screening Committee recommended screening for ages 50 to 74. The region’s 2022-2032 cancer strategy committed to this change, but implementation has been slow.
There remains one significant difference with other UK nations: the FIT threshold. This is the level of blood in a poo sample that triggers referral for further tests. Northern Ireland currently uses 120 micrograms of blood per gram of faeces—the same as England, but higher than Scotland and Wales, which both use 80 micrograms. The threshold was already reduced from 150 to 120 micrograms in April 2023, representing incremental progress. A lower threshold catches more potential cancers but requires more follow-up colonoscopies, placing greater demand on health services.
England began lowering its threshold to 80 micrograms in early 2026, with full rollout expected by March 2028. The Department of Health notes that data from this age expansion will inform future decisions about lowering Northern Ireland’s threshold.
Important distinctions for readers
The Department of Health emphasised that screening is for people without symptoms. Anyone experiencing possible signs of bowel cancer should contact their GP immediately rather than waiting for a screening invitation.
Symptoms include: changes in bowel habits, blood in poo, abdominal pain, unexplained weight loss, or persistent tiredness. These require different diagnostic tests, not the routine screening programme.
Questions that remain
Several important questions follow from this announcement:
- Will the promised £1.7-2 million annual savings materialise, given these figures depend on full implementation by 2031—a timeline that spans multiple political mandates?
- Does the Department have adequate endoscopy capacity to handle increased demand, particularly if the FIT threshold is later lowered to match Scotland and Wales?
- How will the programme address persistent inequalities in screening uptake, given that participation rates vary significantly by geography and deprivation?
- Is this expansion funded by new money or reallocated existing budgets—and what happens if political instability affects health spending?
- Given rising bowel cancer rates among under-50s, will the Department consider whether 50 remains the appropriate lower age limit?
What happens next
The first invitations to 59-year-olds will be posted from 2 November 2026. Eligible individuals registered with a GP will automatically receive kits every two years. Those outside the age range who have concerns about symptoms should speak to their GP or visit the nidirect bowel cancer screening page for more information.
The success of this expansion will depend on participation rates—currently around 67% in Northern Ireland—and whether diagnostic services can manage increased demand without unacceptable delays.